Aura Biosciences Files 2025 Proxy Statement

Ticker: AURA · Form: DEF 14A · Filed: Apr 24, 2025 · CIK: 1501796

Aura Biosciences, INC. DEF 14A Filing Summary
FieldDetail
CompanyAura Biosciences, INC. (AURA)
Form TypeDEF 14A
Filed DateApr 24, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, governance, annual-meeting

TL;DR

Aura Biosciences just dropped its proxy statement for the 2025 meeting. Get ready to vote.

AI Summary

Aura Biosciences, Inc. filed its definitive proxy statement (DEF 14A) on April 24, 2025, for its fiscal year ending December 31, 2024. The filing pertains to the company's annual meeting and related corporate governance matters. The company is based in Boston, MA, and operates in the biological products sector.

Why It Matters

This filing provides shareholders with essential information regarding the company's governance, executive compensation, and voting matters for the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing, which is standard for publicly traded companies and does not inherently indicate new risks.

Key Players & Entities

FAQ

What is the purpose of this DEF 14A filing?

This is a definitive proxy statement filed by Aura Biosciences, Inc. pursuant to Section 14(a) of the Securities Exchange Act of 1934, providing information for shareholders regarding the company's annual meeting and related matters.

When was this filing submitted to the SEC?

The filing was submitted on April 24, 2025.

What is the fiscal year end for Aura Biosciences, Inc. as indicated in the filing?

The fiscal year end for Aura Biosciences, Inc. is December 31.

Where is Aura Biosciences, Inc. located?

Aura Biosciences, Inc. is located at 80 Guest Street, Boston, MA 02135.

What is the SIC code for Aura Biosciences, Inc.?

The Standard Industrial Classification (SIC) code for Aura Biosciences, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 24, 2025 regarding Aura Biosciences, Inc. (AURA).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing